CVS Health Corporation provides a broad range of health services across the United States. Its diversified business model provides relative stability, but potential headwinds include competitive pressures in the healthcare sector. Investors should consider the company's strategic initiatives and market position in evaluating its long-term potential.
The fundamental ratings of CVS Health Corporation indicate satisfactory performance in key areas with room for improvement in others.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5/5 | |
| Return on Equity | 3/5 | |
| Return on Assets | 4/5 | |
| Debt to Equity | 1/5 | |
| Price to Earnings | 1/5 | |
| Price to Book | 4/5 |
A comparison of the historical and current ratings reveals the company’s consistent strengths and areas for growth.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | 3/5 | 5 | 3 | 4 | 1 | 1 | 4 |
| Past Data | 3/5 | 5 | 3 | 4 | 1 | 1 | 4 |
The analyst price targets provide insight into the expected price range for CVS Health Corporation stock.
| High | Low | Median | Consensus |
|---|---|---|---|
| $113 | $90 | $106 | $102.67 |
The majority of analysts recommend CVS Health Corporation as a Buy, supported by favorable fundamentals.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 33 | |
| Hold | 6 | |
| Sell | 0 | |
| Strong Sell | 0 |
CVS Health Corporation's diverse business lines provide stability, with solid performance in its cash flow and asset return metrics. However, areas such as debt management pose risks that need to be addressed. Analysts remain optimistic, expressed by their Buy consensus, with stock price targets reflecting potential for appreciation. Investors should weigh these elements carefully within the context of their individual financial strategy.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.